A conditional mouse model of malignant pleural mesothelioma Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside Year: 2016
Medical pleuroscoy, role in undiagnosed pleural effusion and therapy for pneumothorax and recurrent pleural effusion Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013
Association of biochemical determinants and fibrinous formation in malignant pleural effusion Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016
The role of a pleural service in optimising pleural disease management Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014
Cannabis smoke and pneumothorax Source: International Congress 2014 – Smoking in teenagers and shisha, beedis and cannabis' use in all ages Year: 2014
Biological markers of successful pleurodesis for malignant pleural effusion Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside Year: 2016
Management of malignant pleural effusion Source: Eur Respir J 2001; 18: Suppl. 33, 397s Year: 2001
High fluorescence cells in pleural fluid. Association with pleural malignancy Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013
Hemorrhagic malignant pleural effusion: Diagnosis, survival rate, and response to talc pleurodesis Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014
Idiopathic pleural effusions (IPE) and predictive prognosis Source: International Congress 2015 – Interventional pulmonology for pleural diseases Year: 2015
Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015
An examination of the factors for successful pleurodesis against malignant pleural effusion (MPE) Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016
Ultrasound guided pleural brushing: A new method for obtaining pleural specimen in malignant effusion Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016
Systemic inflammatory repercussions after pleurodesis in an experimental model of pneumothorax Source: Annual Congress 2013 –Chest wall and pleura Year: 2013
Critical issues in pleural fluid examinations: laboratory parameters, tumour markers and cytological methods Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=110 Year: 2002
A novel hypothesis in benign pleural thickening in asbestos exposed patients Source: Annual Congress 2013 –Occupational respiratory diseases: obstructive, interstitial lung diseases and methods of diagnosis Year: 2013
Epidemiology of pleural effusion Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=146 Year: 2002
Talc pleurodesis for malignant pleural effusion - effect on survival: Case-control follow-up study Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014
Analysis of amylase rich pleural effusions Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013